I’ve always thought new RA meds get prescribed to the most risky patients, and therefore you see more adverse events.

I’ve always thought new RA meds get prescribed to the most risky patients, and therefore you see more adverse events. Turns out it’s marginally true - maybe out to five years. Worth being careful of judging new meds too early! #EULAR2024 OP0114 @karolinskainst @RheumNow https://t.co/Q8dIHiIYQk